<?xml version='1.0' encoding='iso-8859-1' ?>
<documents><document>
<title>Health Economic Models</title>
<publication-date>2018-01-01T00:00:00-08:00</publication-date>
<state>published</state>
<authors>
<author>
<email>laurence.djatche@jefferson.edu</email>
<institution>Thomas Jefferson University</institution>
<lname>Djatche</lname>
<fname>Laurence</fname>
</author>
<author>
<email>stefan.varga@jefferson.edu</email>
<institution>Thomas Jefferson University</institution>
<lname>Varga</lname>
<fname>Stefan</fname>
</author>
<author>
<email>rliebert@utk.edu</email>
<institution>University of Tennessee, Knoxville</institution>
<lname>Lieberthal</lname>
<fname>Robert</fname>
<mname>D.</mname>
</author>
</authors>
<keywords>
<keyword>cost-effectiveness analysis</keyword>
<keyword>aspirin</keyword>
<keyword>secondary prevention</keyword>
<keyword>cardiovascular disease</keyword>
<keyword>adherence</keyword>
<keyword>health economic modeling</keyword>
</keywords>
<abstract>&lt;p&gt;These health economic models calculate the impact of aspirin adherence on healthcare costs and quality adjusted life years in patients with a prior cardiovascular event from a payer perspective. The “no diabetes” model is for patients with a history of cardiovascular disease who do not have diabetes as a comorbid condition. The “diabetes” model is for patients with a history of cardiovascular disease who have type II diabetes as a comorbid condition. These .trex files are designed to be loaded and run in TreeAge software Pro Core 2016 health economic modeling software.&lt;/p&gt;</abstract>
<coverpage-url>https://trace.tennessee.edu/utk_publichealth/4</coverpage-url>
<label>4</label>
<document-type>data</document-type>
<type>article</type>
<articleid>1003</articleid>
<submission-date>2018-03-05T06:40:09-08:00</submission-date>
<native-url>https://trace.tennessee.edu/context/utk_publichealth/article/1003/type/native/viewcontent</native-url>
<publication-title>Public Health Publications and Other Works</publication-title>
<context-key>11698110</context-key>
<submission-path>utk_publichealth/4</submission-path>
<fields>
<field name="comments" type="string">
<value>&lt;p&gt;Data associated with the following article: https://link.springer.com/article/10.1007%2Fs41669-018-0075-2&lt;/p&gt;
&lt;p&gt;Laurence M. Djatche, Stefan Varga, and Robert D. Lieberthal. &quot;Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events.&quot; PharmacoEconomics 2018&lt;/p&gt;</value>
</field>
<field name="publication_date" type="date">
<value>2018-01-01T00:00:00-08:00</value>
</field>
</fields>
<supplemental-files>
<file>
<archive-name>QALYs_NoDiabetes_FINAL.trex</archive-name>
<upload-name>QALYs_NoDiabetes_FINAL.trex</upload-name>
<url>https://trace.tennessee.edu/cgi/viewcontent.cgi?filename=0&amp;amp;article=1003&amp;amp;context=utk_publichealth&amp;amp;type=additional</url>
<mime-type>application/xml</mime-type>
</file>
<file>
<archive-name>QALYs_ComorbidDiabetes_FINAL.trex</archive-name>
<upload-name>QALYs_ComorbidDiabetes_FINAL.trex</upload-name>
<url>https://trace.tennessee.edu/cgi/viewcontent.cgi?filename=1&amp;amp;article=1003&amp;amp;context=utk_publichealth&amp;amp;type=additional</url>
<mime-type>application/xml</mime-type>
</file>
</supplemental-files>
</document>
</documents>